Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
05/2004
05/27/2004WO2003040367A8 Method of forming self-assembly by oligonucleotide synthesized by gene amplification reaction and method of detecting self-assembly and gene
05/27/2004WO2003026488A3 Diagnosis and treatment of vascular disease
05/27/2004WO2003014986A8 Method for predicting the formation of mould fungi
05/27/2004WO2003010507A3 System for intracellular process monitoring and in vivo drug screening
05/27/2004WO2003004604A3 Phage displayed pdz domain ligands
05/27/2004WO2002102854A3 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
05/27/2004WO2002099141A9 Fluorescent quenching detection reagents and methods
05/27/2004WO2002097037A8 Melanin-concentrating hormone analogs
05/27/2004WO2002093131A3 Methods for isolating and labeling sample molecules
05/27/2004WO2002092827A3 Corona-virus-like particles comprising functionally deleted genomes
05/27/2004WO2002085923A3 In vivo incorporation of unnatural amino acids
05/27/2004WO2002084288A9 Individualization of therapy with antiarrhythmics
05/27/2004WO2002079393A3 Dynamic action reference tools
05/27/2004WO2002072892A9 Methods and apparatus for analyzing polynucleotide sequences by asynchronous base extension
05/27/2004WO2002055721B1 Modular transfection systems based on nucleoprotein filaments
05/27/2004WO2001066563A3 T1r taste receptors and genes encoding same
05/27/2004WO2000073764A3 Composition and methods for the therapeutic use of an atonal-associated sequence
05/27/2004WO1999046281A8 Novel polypeptides and nucleic acids encoding the same
05/27/2004US20040103452 Increasing proability of asexual reproduction in transgenic plants using nucleotide sequences coding somatic embryogenesis receptor kinase and auxin administration
05/27/2004US20040102905 Monitoring gene expession; using computers; analyzing phenotypes; classification
05/27/2004US20040102714 Cytological evaluation of breast duct epithelial cells retrieved by ductal lavage
05/27/2004US20040102624 Compositions and methods for regulating autolytic processes in bacteria
05/27/2004US20040102407 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
05/27/2004US20040102405 Using compounds comprising oligonucleotides targeted to nucleic acid encoding squalene synthase; for diagnosis and treatment of disease associated with expression of squalene synthase; cardiovascular disorders, atherosclerosis
05/27/2004US20040102404 Modulation of KU86 expression
05/27/2004US20040102403 Using compounds comprising oligonucleotides targeted to fibrillarin; for diagnosis and treatment of disease associated with expression of fibrillarin; proliferative disorders, cancer
05/27/2004US20040102401 Using compounds comprising oligonucleotides targeted to nucleic acid encoding jagged 1; for diagnosis and treatment of disease associated with expression of jagged 1; developmental disorders, cancer
05/27/2004US20040102394 Using compositions comprising oligonucleotides targeted to nucleic acid encoding huntingtin interacting protein 2; for diagnosis and treatment of disease associated with expression of huntingtin interacting protein 2
05/27/2004US20040102390 Modulation of Notch3 expression
05/27/2004US20040102379 Fibroblast growth factor homologous factors (FHFs) and methods of use
05/27/2004US20040101975 Method for analysing macromolecules
05/27/2004US20040101953 Raised surface assay plate
05/27/2004US20040101946 Method of using ammonia-oxidizing bacteria
05/27/2004US20040101927 Comprises nucleotide sequences coding polypeptides for diagnosis, prognosis, prevention and treatment of neurodegenerative and cancer disorders
05/27/2004US20040101926 Nutrient broth for propagation and identification of drug/antibiotic resistant tubercle bacilli
05/27/2004US20040101925 Identifying insects which have elevated mixed function oxidase activity using colorimetric analysis
05/27/2004US20040101924 Proteolytic enzymes in urine as diagnostic parameters in diseases involving matrix remodelling
05/27/2004US20040101923 Container containing containers of a neutral to acid pH phosphate buffer, acetylcholine iodide, propoxur, 5,5-dithio-bis-(2-nitrobenzoic acid), and a water miscible solvent for colorimetric analysis of actylcholine esterase
05/27/2004US20040101922 Method for detecting transferase enzymatic activity
05/27/2004US20040101921 Process for label-free measurement of modified substrate
05/27/2004US20040101917 Methods for managing animal processing operations
05/27/2004US20040101916 Using decreased expression of growth arrest and DNA-damage-inducible gene 45 beta (GADD45 beta) to diagnose cirrhosis and liver cancer
05/27/2004US20040101915 Diagnosis and treatment of chemoresistant tumors
05/27/2004US20040101912 Using fluorescent assay to identify parathyroid hormone receptor ligands and modulators which effect internalization of luminescent signal
05/27/2004US20040101911 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
05/27/2004US20040101902 Contacting an agent with a cell-free system which contains PPAR-gamma, permits the expression of early growth response gene-1 and inhibits such expression in presence of PPAR-gamma agonist, stimulating cell free system to increase Egr-1
05/27/2004US20040101898 Cytogenetically determined prognosis of myeloma
05/27/2004US20040101897 Production method for purine nucleotide derivative disodium crystals and alcohol removing method
05/27/2004US20040101894 Microarrays having multiple oligonucleotides in single array features
05/27/2004US20040101893 Abasic site endonuclease assay
05/27/2004US20040101892 Nucleic acid labeling compounds
05/27/2004US20040101891 Simple and accurate detection of nucleotide polymorphisms in nucleic acid target molecules; method may be applied for diagnostic purposes, e.g. for determining predisposition of diseases associated with specific nucleotide polymorphisms
05/27/2004US20040101890 Nucleic acid mediated electron transfer
05/27/2004US20040101889 Method of detection by enhancement of silver staining
05/27/2004US20040101888 Vector system used in screening active substances
05/27/2004US20040101886 Nucleotide sequences comprising regions of dyad symetry for replication, identification and quantification of DNA sequences coding immunoglobulins; antibody libraries
05/27/2004US20040101882 Secreted proteins
05/27/2004US20040101881 Fluid mixture comprising nucleic acid oxidizing agent/sodium hypochlorite and surfactant for removing and helix-destabilizing amplifiable nucleotide sequences on bench, counter tops and solid surfaces; decontamination
05/27/2004US20040101879 Using histidyl tRNA synthetase (HisRS) to identify modulators of sterol regulatory element binding protein (SREBP) activity and treat cardiovascular and ateriosclerosis
05/27/2004US20040101876 Methods and systems for annotating biomolecular sequences
05/27/2004US20040101873 Classifying, identifying and determining sequence of large nucleic acid molecules using mass spectroscopy; restriction fragment length polymorphisms; forensics; heredity testing
05/27/2004US20040101872 Lipocalins
05/27/2004US20040101871 Regulation of human gpcr-like protein
05/27/2004US20040101869 Liposome; virus protein overcoating of interior nucleic acid; quantitative analysis
05/27/2004US20040101868 Analysis method for hemochromatosis mutation
05/27/2004US20040101867 Use of microbial dna sequences for the identification of human diseases
05/27/2004US20040101866 Determining microorganism concentration in skin; monitoring efficiency of fungicide preventing fungal propagation
05/27/2004US20040101865 Comprises nucleotide sequences coding polypeptides associated with biosynthesis and metabolism of acetyl-CoA for preparing food, feed, cosmetics and pharmaceutical agents
05/27/2004US20040101863 Using abnormalities in low density lipoprotein receptor to diagnose and treat arteriosclerosis and ischemic heart disorders
05/27/2004US20040101860 Using chaperonin 60 expression pattern to determine health profile of animals; veterinary medicine; animal husbandry
05/27/2004US20040101859 Compositions, methods and kits for polynucleotide amplification reactions and microfluidic devices
05/27/2004US20040101855 Modulation of PPAR binding protein expression
05/27/2004US20040101854 Modulation of BCL2-associated athanogene expression
05/27/2004US20040101853 Modulation of STAT2 expression
05/27/2004US20040101851 Identifying chemical warfare agents and explosive agents using immobilized fluorescent nucleotides; microarrays
05/27/2004US20040101850 Antisense nucleotide sequences for treatment of hyperactive immune response disorders
05/27/2004US20040101846 Methods for identifying suitable nucleic acid probe sequences for use in nucleic acid arrays
05/27/2004US20040101845 Identifying nucleic acid sequences for use as substrate surface immobilized probe; gene expression analysis; genomics and disease diagnosis
05/27/2004US20040101844 Methods and compositions for producing linearly amplified amounts of (+) strand RNA
05/27/2004US20040101843 Detection of methylated DNA sites
05/27/2004US20040101842 Method to screen for improved meat characteristics in pigs
05/27/2004US20040101840 Comprises nucleotide sequences coding acyclovir/gancyclovir/prostate specific protein fusion for use in diagnosis, prevention and treatment of cell proliferative disorders
05/27/2004US20040101838 Enzyme-based regeneration of surface-attached nucleic acids
05/27/2004US20040101836 Amplification, transfection nucleic acids; genetic engineering; diagnosis of cancer;
05/27/2004US20040101835 Using circularized probe to detect, amplify and sequence target nucleotide sequences; restriction fragment length polymorphisms
05/27/2004US20040101834 Identifying and monitoring antitumor agent sensitivity in cells with mutations in genes associated folate metabolism; folate analogs as anticarcinogenic agents
05/27/2004US20040101830 Method for identifying individual active entities from complex mixtures
05/27/2004US20040101828 Classification of phenotypic manifestations in viral allelic variants; monitoring infectivity, replicative capacity and virulence of viral variants
05/27/2004US20040101826 Monitoring high-risk environments
05/27/2004US20040101823 HIV-1 viral variants for improved animal models of HIV-1 pathogenesis
05/27/2004US20040101821 Antiviral antisense therapy
05/27/2004US20040101820 Polynucleotide probe and primer originating in hepatitis e virus of japanese, chips having the same, kits having the same and method of detecting hepatits e virus using the same
05/27/2004US20040101819 Self-assembled muscle-powered microdevices
05/27/2004US20040101741 Enzyme immobilization for use in biofuel cells and sensors
05/27/2004US20040101594 Excellent in flavor and taste and weak in fermentation smell
05/27/2004US20040101581 Chinese herbs extract
05/27/2004US20040101537 Mixture of oligonucleotide and fine particles of biodegradation polymer; concurrent administering of protein antigen
05/27/2004US20040101529 Regulation of human serine-threonine protein kinase
05/27/2004US20040101528 Type I IL-1 receptors
05/27/2004US20040101478 Determination phosphorylation of sampling; measurement, calibration